Clinical Reference Laboratory Service Market Report 2026

The clinical reference laboratory service market size has grown strongly in recent years. It will grow from $18.98 billion in 2025 to $20.83 billion in 2026 at a compound annual growth rate (CAGR) of 9.7%. The growth in the historic period can be attributed to increasing outsourcing of diagnostic testing, expansion of centralized laboratory networks, rising demand for specialty diagnostics, growth in hospital referral testing volumes, availability of advanced laboratory technologies.

The clinical reference laboratory service market size is expected to see strong growth in the next few years. It will grow to $29.87 billion in 2030 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to increasing adoption of precision medicine diagnostics, expansion of genomic and molecular testing services, rising investments in laboratory automation, growing demand for high-throughput testing capacity, increasing integration of digital laboratory platforms. Major trends in the forecast period include increasing centralization of high-complexity diagnostic testing, rising adoption of automated reference laboratory systems, growing demand for specialized and genetic testing services, expansion of integrated laboratory information systems, enhanced focus on quality and regulatory compliance.

The increasing demand for personalized medicine is expected to drive the growth of the clinical reference laboratory service market going forward. Personalized medicine is a medical approach that uses information about an individual’s genetic profile and lifestyle to tailor healthcare and treatments to their specific needs. The rise in personalized medicine is fueled by the growing preference for more individualized healthcare that accounts for unique genetic and environmental factors. Clinical reference laboratory services support personalized medicine by providing precise genetic testing and pharmacogenomic analyses, enabling treatments to be customized to a patient’s genetic profile. For instance, in February 2024, according to the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, the U.S. Food and Drug Administration (FDA) approved 26 new personalized medicines in 2023, a notable increase from the 12 approved in 2022. Therefore, the increasing demand for personalized medicine is propelling the growth of the clinical reference laboratory service market.

Major companies operating in the clinical reference laboratory service market are focusing on innovations in diagnostic technologies, such as next-generation laboratory automation, to improve testing accuracy, operational efficiency, and turnaround times. Next-generation laboratory automation involves integrating advanced technologies, including robotics, artificial intelligence (AI), machine learning, and data analytics, to optimize and streamline laboratory workflows. For instance, in May 2025, Apollo Diagnostics, an India-based provider of comprehensive diagnostic and pathology services, launched the fully automated Digi-Smart central reference laboratory in Chennai. The 45,000-square-foot facility is designed to reduce laboratory sample turnaround time (TAT) by 60% and features advanced robotics and next-generation laboratory automation for seamless sample processing with minimal human intervention. It integrates AI-powered diagnostic tools, real-time data tracking, and end-to-end digital workflow management, resulting in faster TAT, improved accuracy, and reduced errors. The lab also supports high-throughput testing, enabling efficient handling of large volumes of diagnostic samples while maintaining strict quality standards.

In April 2024, Eurofins Scientific SE, a Luxembourg-based testing laboratory company, acquired Ascend Clinical for an undisclosed amount. This acquisition allows Eurofins to strengthen its presence in the U.S. renal and transplant diagnostics market by incorporating Ascend Clinical’s highly automated laboratory services for kidney dialysis and related testing. Ascend Clinical LLC is a US-based clinical reference laboratory company.

Major companies operating in the clinical reference laboratory service market are Laboratory Corporation of America Holdings, Mayo Clinic Laboratories, Quest Diagnostics Incorporated, Eurofins Scientific SE, Sonic Healthcare Limited, SYNLAB International GmbH, OPKO Health Inc, Unilabs AB, LifeLabs Medical Laboratory Services, ARUP Laboratories, Dr Lal PathLabs Limited, PathGroup Inc, Clinical Reference Laboratory Inc, ACCU Reference Medical Lab LLC, ACM Global Laboratories, Genova Diagnostics Inc, Cerba HealthCare Group, MedLabs Diagnostics, Apollo Diagnostics, Health Services Laboratories.

North America was the largest region in the clinical reference laboratory service market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the clinical reference laboratory service market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the clinical reference laboratory service market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the clinical reference laboratory service market by increasing costs of imported automated analyzers, genetic testing platforms, laboratory robotics, reagents, and information systems. Reference laboratories in North America and Europe are most affected due to reliance on imported high-end laboratory equipment, while Asia-Pacific faces higher costs for advanced diagnostic technology imports. These tariffs are increasing capital expenditure requirements and slowing laboratory expansion. However, they are also encouraging domestic equipment manufacturing, regional laboratory infrastructure development, and greater investment in local diagnostic innovation.

The clinical reference laboratory service market research report is one of a series of new reports that provides clinical reference laboratory service market statistics, including clinical reference laboratory service industry global market size, regional shares, competitors with a clinical reference laboratory service market share, detailed clinical reference laboratory service market segments, market trends and opportunities, and any further data you may need to thrive in the clinical reference laboratory service industry. This clinical reference laboratory service market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Clinical reference laboratory service refers to a specialized laboratory service that provides diagnostic testing and analytical services for healthcare providers, hospitals, clinics, and other laboratories. These services are typically performed by large, centralized laboratories that offer a wide array of high-complexity and specialty tests, which may not be available in smaller or on-site hospital labs.

The primary types of clinical reference laboratory service are clinical chemistry, hematology, microbiology, cytology, genetic testing, and others. Clinical chemistry refers to a branch of laboratory medicine that focuses on the analysis of bodily fluids, primarily blood and urine, to diagnose and monitor diseases. The multiple sample types involved - such as blood, urine, tissue, and saliva - are used with various technologies, including laboratory information systems (LIS), automated laboratory equipment, point-of-care testing, and others. These services are applied in disease diagnosis, drug development, precision medicine, and other applications, and cater to several end users, including hospitals, diagnostic laboratories, academic institutes, and pharmaceutical companies.

The clinical reference laboratory service market consists of revenues earned by entities by providing services such as routine clinical testing, microbiology and infectious disease testing, molecular diagnostics, immunology and serology, and toxicology and drug testing. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.